Actively Recruiting
Connect2Care: A Randomized Clinical Trial of a Smartphone-based Application for Prostate Cancer Education and Screenings for African American Men
Led by University of Oklahoma · Updated on 2025-09-25
466
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Prostate cancer is the most commonly diagnosed cancer and the second-leading cause of cancer death among African American men. This research aims to evaluate the Connect2Care App, designed to improve knowledge about prostate cancer, screening benefits, and risks, and to increase readiness for the prostate-specific antigen (PSA) test. The study compares this app to an existing U.S. Department of Health & Human Services app in a randomized control trial involving African American men aged 45 to 69 in Oklahoma who are not up to date with PSA screening. Participants will be randomly assigned to use either the Prostate Cancer Genius App, which offers culturally tailored educational content, real-time messages, quizzes, testimonials, counseling options, and automated home PSA test ordering; or the Prevention Taskforce App, which provides evidence-based prostate cancer information and a companion app for assessments and home PSA test ordering. Both apps are used over a 30-day period, with follow-up support and navigation for social needs referrals provided. During the study, participants’ knowledge of prostate cancer and screening, app engagement, and acceptability will be assessed through questionnaires and interviews. Researchers will measure PSA screening rates 30 days after enrollment and explore readiness for testing. The study also includes community outreach efforts offering education and free PSA tests. Overall participation lasts about one month with active monitoring and follow-up care options available.
CONDITIONS
Brief Title
Connect2Care: Prostate Cancer Education and Screenings for African American Men
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Live in Oklahoma
- Self-identify as Black/African American
- Self-identify as male
- Between ages 45-69
- Not currently diagnosed with prostate cancer
You will not qualify if you...
- Not interested in using a phone app for 30 days
- Has taken a PSA test or completed PSA screening within the past two years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 30 days
Participants use their assigned smartphone app for one month to learn about prostate cancer and screening, receive educational content, and access home-based PSA test kits with navigation support.
Weekly app interactions and assessments
Trial Site Locations
Total: 1 location
1
TSET Health Promotion Research Center
Oklahoma City, Oklahoma, United States, 73104
Actively Recruiting
Research Team
J
Jordan Neil, PhD
A
Adam Alexander, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here